NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
This Quarter Return
-4.07%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$996M
AUM Growth
+$996M
(-2.4%)
Cap. Flow
+$58.7M
Cap. Flow
% of AUM
5.9%
Top 10 Holdings %
Top 10 Hldgs %
46.87%
Holding
137
New
19
Increased
25
Reduced
38
Closed
13
Top Buys
| 1 |
Soleno Therapeutics
SLNO
|
$27.4M |
| 2 |
Establishment Labs
ESTA
|
$24.9M |
| 3 |
Peloton Interactive
PTON
|
$15.6M |
| 4 |
Savara
SVRA
|
$13.9M |
| 5 |
The Bancorp
TBBK
|
$12.8M |
Top Sells
| 1 |
Pathward Financial
CASH
|
$27.2M |
| 2 |
Lyra Therapeutics
LYRA
|
$17.5M |
| 3 |
Red Violet
RDVT
|
$16.9M |
| 4 |
Dyne Therapeutics
DYN
|
$12.4M |
| 5 |
Golden Entertainment
GDEN
|
$9.92M |
Sector Composition
| 1 | Healthcare | 68.09% |
| 2 | Consumer Discretionary | 12.03% |
| 3 | Financials | 6.24% |
| 4 | Communication Services | 6.07% |
| 5 | Technology | 3.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Soleno Therapeutics
SLNO
$3.6B
| $126M | 7.35% | 3,082,107 +671,728 | +28% | +$27.4M |
|
|
2
Establishment Labs
ESTA
$1.2B
| $114M | 6.67% | 2,512,850 +548,288 | +28% | +$24.9M |
|
|
3
Peloton Interactive
PTON
$3.1B
| $37M | 2.16% | 10,935,331 +4,622,392 | +73% | +$15.6M |
|
4
Evolus
EOLS
$494M
| $31.6M | 1.85% | 2,910,849 | – | – |
|
5
Bioventus
BVS
$495M
| $30.7M | 1.79% | 5,338,314 -467,698 | -8% | -$2.69M |
|
|
6
Pathward Financial
CASH
$1.82B
| $30.6M | 1.79% | 541,433 -480,294 | -47% | -$27.2M |
|
7
IMAX
IMAX
$1.54B
| $30.2M | 1.76% | 1,798,260 -404,917 | -18% | -$6.79M |
|
8
Hilton Grand Vacations
HGV
$4.24B
| $27M | 1.58% | 668,871 | – | – |
|
|
9
Savara
SVRA
$567M
| $20.9M | 1.22% | 5,180,951 +3,443,541 | +198% | +$13.9M |
|
10
America's Car Mart
CRMT
$371M
| $18.8M | 1.1% | 312,128 | – | – |
|
|
RDNW
11
RideNow Group, Inc. Class B Common Stock
RDNW
$147M
| $18.1M | 1.06% | 4,416,506 | – | – |
|
12
Keros Therapeutics
KROS
$618M
| $17.3M | 1.01% | 378,807 +84,810 | +29% | +$3.88M |
|
13
Amneal Pharmaceuticals
AMRX
$3B
| $17M | 0.99% | 2,669,943 +50,000 | +2% | +$318K |
|
14
Abeona Therapeutics
ABEO
$350M
| $14.7M | 0.86% | 3,470,037 +1,159,397 | +50% | +$4.92M |
|
|
OPTN
15
DELISTED
OptiNose
OPTN
| $14.4M | 0.84% | 13,418,740 +10,944,444 | +442% | +$11.8M |
|
|
ABVX
16
Abivax
ABVX
$6.12B
| $13M | 0.76% | 985,634 -24,400 | -2% | -$323K |
|
17
Rezolute
RZLT
$619M
| $12.9M | 0.75% | 2,989,963 -32,984 | -1% | -$142K |
|
|
18
The Bancorp
TBBK
$3.51B
| $12.8M | 0.75% | +337,846 | New | +$12.8M |
|
19
Reservoir Media
RSVR
$517M
| $12.3M | 0.72% | 1,550,797 | – | – |
|
20
uniQure
QURE
$896M
| $11.9M | 0.69% | 2,650,472 -437,610 | -14% | -$1.96M |
|
21
Zevra Therapeutics
ZVRA
$509M
| $11.9M | 0.69% | 2,419,435 -33,970 | -1% | -$166K |
|
22
Payoneer
PAYO
$2.5B
| $11.7M | 0.69% | 2,115,653 +294,227 | +16% | +$1.63M |
|
23
Assertio
ASRT
$80.4M
| $11.5M | 0.67% | 9,270,836 | – | – |
|
24
TELA Bio
TELA
$70.5M
| $11.5M | 0.67% | 2,445,667 +1,347,801 | +123% | +$6.33M |
|
|
25
Red Violet
RDVT
$702M
| $11.5M | 0.67% | 452,457 -663,792 | -59% | -$16.9M |
|